The current price, which is partially a function of supply / demand, is putting pressure even on institutions abilities to keep the drugs stocked
No serious adverse events, hospitalization, organ damage, or deaths have been documented in over 100 preclinical studies, even at doses 1,000 times higher than typical therapeutic use
10961 - 10970][Angew
Understanding the GLP-1 consumer The GLP-1 era has given rise to multiple distinct consumer types, each with shared, yet nuanced, nutritional needs: Consumers currently using GLP-1 therapies face unique challenges, including appetite suppression that can make meeting nutritional requirements difficult, potential gastrointestinal side effects and concerns about maintaining muscle mass during weight loss
The trade-off is that the anabolic effect is more subtle and takes longer to manifest